Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis.

Added 2375 days ago (26.12.2015)

Authors: Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P, Deodhar A, Porter B, Martin R, Andersson M, Mpofu S, Richards HB, MEASURE 1 Study Group, MEASURE 2 Study Group